ArticleEuropean journal of sport science2025
Nonsteroid Anti-Inflammatory Drug Use in Female Elite Ice Hockey Players With and Without Previous Concussions and Musculoskeletal Injuries.
Article in European journal of sport science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence of self-reported asthma among female ice hockey players in the Swedish women's hockey league.Frontiers in sports and active living · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ice hockey is a high-intensity sport with high rates of concussions and musculoskeletal injuries. To manage pain, players may (over) use nonsteroid anti-inflammatory drugs (NSAIDs) which can have adverse health effects. In 2022, the Swedish Women's Elite League (SDHL) became the first women's league to introduce body checking, potentially increasing injury risks and NSAID use. This study examines NSAID consumption among SDHL players and its associations with concussions and musculoskeletal injuries. All 224 players registered in SDHL 2023/2024 were invited to participate. The data of 158 included players (71%) aged (mean ± standard deviation) 23.4 ± 4.5 years were analyzed. NSAID use, concussions and musculoskeletal injury rates were assessed through a self-reported questionnaire. In all players, 18% used NSAID at least once weekly, 15% used them one to three times per week, and 3% used them four to seven times per week. Players with previous concussions without persistent symptoms or musculoskeletal injuries did not have significantly higher odds of using more NSAIDs than those without. Players with persistent symptoms after concussion(s) were approximately five times more likely to use NSAIDs weekly than those with previous concussion(s) but without persistent symptoms (Odds Ratio (95% confidence interval): 4.9 (1.1, 21.3)) (p < 0.05). In conclusion, almost one-fifth of female ice hockey players used NSAIDs weekly. Players with persistent post-concussion symptoms are a subgroup that should be monitored more closely to prevent excessive NSAID use. The observed NSAID usage rates presented in this study represent important (baseline) reference values in female ice hockey players allowed to body check.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.